Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.46-24.787.6324.25407.44

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -23.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-23.46
Mar2024-24.78
Mar20237.63
Mar202224.25
Mar2021407.44

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.46
Negative
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25
-94.05
Mar2021 407.44 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹156.2 Cr -0.4% -20.4% -62.6% Stock Analytics
ADANI ENTERPRISES ₹291,855.0 Cr 1.2% 0.8% -10.9% Stock Analytics
REDINGTON ₹21,483.2 Cr 1.4% -1.9% 44.2% Stock Analytics
MMTC ₹9,859.5 Cr 2.4% 10.8% -6.2% Stock Analytics
LLOYDS ENTERPRISES ₹9,563.9 Cr 0.2% 12.3% 37.2% Stock Analytics
HONASA CONSUMER ₹9,232.4 Cr 5.6% -0.7% 14.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.4%

-20.4%

-62.6%

SENSEX

-0.3%

-0.5%

8.3%


You may also like the below Video Courses